蛋白降解，分子胶赛道。VAV1等合作。首付款，预付款1.2亿美金。
NVS and Monte Rosa Therapeutics entered into a licensing agreement valued at up to $5.7 billion. The collaboration aims to develop drugs for immune-mediated diseases$诺华制药(NVS)$ $Monte Rosa(GLUE)$ #Seeking# #biotech#